Publications - Page 2 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Pneumopathies interstitielles diffuses (PID)
The significance of multidisciplinary team meetings in diagnosing and managing childhood interstitial lung disease within the RespiRare network.

Cassibba J, Epaud R, Berteloot L, Aberbache S, Bitton L, Fletcher C, Fleury M, Delestrain C, Corvol H, de Becdelièvre A, Borie R, Legendre M, Coulomb l'Herminé A, Louvrier C, Lustremant C, Sari Hassoun M, Sileo C, Hadchouel A, Nathan N.

Pediatr Pulmonol. 2023 Nov 22.
Transplantation pulmonaire
Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis.

Heritier S, Donadieu J, Leger PL, De Tersant M, Della Vallee V, Barkaoui MA, Le Louet S, Tazi A, Taytard J, Corvol H, Helias-Rodzevicz Z, Emile JF, Fadel E, Fabre D, Feuillet S, Nathan N.

Pediatr Pulmonol. 2023 Oct 4.
Anomalies du développement pulmonaire (ADP)
Acinar Dysplasia in a Full-Term Newborn with a NKX2.1 Variant.

Soreze Y, Nathan N, Jegard J, Hervieux E, Clermidi P, Sileo C, Louvrier C, Legendre M, Coulomb L'Herminé A.

Neonatology. 2023 Nov 30:1-4.
Pneumopathies interstitielles diffuses (PID)
Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database.

Juge PA, Wemeau L, Ottaviani S, Desjeux G, Zhuo J, Vannier-Moreau V, Flipo RM, Crestani B, Dieudé P.

RMD Open. 2023 Dec 1;9(4):e003491.
Pneumopathies interstitielles diffuses (PID)
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease.

Doyle TJ, Juge PA, Peljto AL, Lee S, Walts AD, Esposito AJ, Poli S, Gill R, Hatabu H, Nishino M, Dellaripa PF, Weinblatt ME, Shadick NA, Demoruelle MK, Sparks JA, Rosas IO, Granger B, Deane KD, Crestani B, Wolters PJ, Dieudé P, Lee JS.

Thorax. 2023 Dec 7:thorax-2023-220022.
Pneumopathies interstitielles diffuses (PID)
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).

Joannes A, Voisin T, Morzadec C, Letellier A, Gutierrez FL, Chiforeanu DC, Le Naoures C, Guillot S, De Latour BR, Rouze S, Jaillet M, Crestani B, Wollin L, Jouneau S, Vernhet L.

Pulm Pharmacol Ther. 2023 Dec;83:102267.
Fibrose pulmonaire - FPI
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.

Kreuter M, Bendstrup E, Jouneau S, Maher TM, Inoue Y, Miede C, Lievens D, Crestani B.

Respir Res. 2023 Mar 9;24(1):71.
Fibrose pulmonaire - FPI
Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis

Marchal-Duval E, Homps-Legrand M, Froidure A, Jaillet M, Ghanem M, Lou D, Justet A, Maurac A, Vadel A, Fortas E, Cazes A, Joannes A, Giersh L, Mal H, Mordant P, Piolot T, Truchin M, Mounier CM, Schirduan K, Korfei M, Gunther A, Mari B, Jaschinski F, Crestani B, Mailleux AA.

Elife. 2023 Jun 1;12:e79840.
Fibrose pulmonaire - FPI
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.

Respir Res. 2023 Mar 20;24(1):87.
Pneumopathies interstitielles diffuses (PID)
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.

Mabo A, Borie R, Wemeau-Stervinou L, Uzunhan Y, Gomez E, Prevot G, Reynaud-Gaubert M, Traclet J, Bergot E, Cadranel J, Marchand-Adam S, Bergeron A, Blanchard E, Bondue B, Bonniaud P, Bourdin A, Burgel PR, Hirschi S, Marquette CH, Quétant S, Nunes H, Chenivesse C, Crestani B, Guirriec Y, Monnier D, Ménard C, Tattevin P, Cottin V, Luque Paz D, Jouneau S; OrphaLung Network.

Thorax. 2023 Sep 27:thorax-2023-220040.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

The significance of multidisciplinary team meetings in diagnosing and managing childhood interstitial lung disease within the RespiRare network.

Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis.

Acinar Dysplasia in a Full-Term Newborn with a NKX2.1 Variant.

Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database.

Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease.

Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).

Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.

Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.

Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.